Rukobia
Fostemsavir Data Looking Bright for Heavily Treatment-Experienced Adults With MDR HIV
After 240 weeks, fostemsavir helped HTE adults with MDR HIV-1 infection achieve durable virologic responses, ...
AUGUST 3, 2022
Better Options Available For Multidrug-Resistant HIV
Patients with MDR HIV make up a small but challenging group living with HIV. With careful monitoring and new drugs ...
JANUARY 7, 2021
Load more